Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
An internal technical investigation has confirmed that legionella pneumophila 2-14 reagent lot: 1265366 may return false negative results. this reagent is contained within the following products: oxoid legionella latex test (dr0800m) lots 1314413 and 1301907. continued use of these lots may result in a delay to the correct serogroup characterisation of legionella isolates.